PDT Partners’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-167,749
| Closed | -$419K | – | 640 |
|
|
2022
Q4 | $419K | Sell |
167,749
-136,710
| -45% | -$342K | 0.07% | 421 |
|
|
2022
Q3 | $1.29M | Sell |
304,459
-65,475
| -18% | -$276K | 0.19% | 153 |
|
|
2022
Q2 | $1.03M | Sell |
369,934
-129,897
| -26% | -$362K | 0.09% | 384 |
|
|
2022
Q1 | $2.86M | Buy |
499,831
+436,461
| +689% | +$2.5M | 0.25% | 107 |
|
|
2021
Q4 | $579K | Buy |
+63,370
| New | +$579K | 0.04% | 492 |
|
|
2021
Q2 | – | Sell |
-36,028
| Closed | -$584K | – | 875 |
|
|
2021
Q1 | $584K | Buy |
+36,028
| New | +$584K | 0.04% | 478 |
|